SBIR Opportunity Leverage the recent SBIR fast-track Phase 1/2 award to position InVivo Analytics as a validated, grant-backed innovator in modular bioluminescence imaging; potential upsell to expanded platform modules and enterprise licensing for preclinical facilities pursuing similar funding.

Small Team, Agility With a lean team of 2-10 employees, there is a strong need for scalable, automated data analysis and cloud-friendly deployments. Target collaborations or channel partnerships that offer turnkey integrations to reduce deployment burden and accelerate time-to-value for customers.

Throughput & Reproducibility Position the product as a solution to increase data throughput and reproducibility while cutting human error and bias; identify mid-size preclinical labs and CROs seeking efficiency gains and consistent imaging analytics as primary use cases for expansion.

Funding-Driven Growth With current revenue in the low millions and SBIR traction, explore opportunities near funded research programs, biopharma partnerships, or government grants where shared analytics workflows can align with grant milestones and budget cycles.

Competitive Positioning Benchmark against larger AI and data analytics vendors by emphasizing specialized preclinical imaging domain expertise, modular architecture, and cost-conscious deployment; propose pilot programs to demonstrate ROI against incumbents in similar markets.